Stock & Company Details
Aldeyra Therapeutics Inc $ALDX
Price:
N/A
N/A
60M
$57M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALDX technical indicators
Latest Aldeyra Therapeutics Inc (ALDX) indicator readings as of 2026-10-09.
ALDX's 14-day RSI is 29.9, in oversold territory. At $0.92 it is trading 64.4% below its 200-day moving average of $2.57, and below its 50-day average of $1.40. Price sits near the lower Bollinger Band ($0.86 to $1.57). ADX reads 30.1, indicating a trending market.
Overview
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Finance Bot
Ask your questions
Start by typing a question below.
